LIMITATION OF LIABILITY AND ASSUMPTION OF RISK AGREEMENT

Document Version: 3.1 Effective Date: January 1, 2025 Document ID: UL-LEGAL-LW-031

---

RECITALS

WHEREAS, Unzyme Laboratories Corporation (“Company”) provides human enhancement products and services;

WHEREAS, the undersigned individual (“Recipient”) desires to receive enhancement products and/or services from the Company;

WHEREAS, human enhancement involves inherent risks that cannot be fully eliminated;

NOW THEREFORE, in consideration of the Company agreeing to provide enhancement products and services, Recipient agrees as follows:

---

ARTICLE I: ASSUMPTION OF RISK

Section 1.1: Voluntary Participation

Recipient acknowledges that participation in enhancement procedures is entirely voluntary. Recipient has chosen to undergo enhancement with full knowledge of associated risks.

Section 1.2: Inherent Risks

Recipient acknowledges that enhancement procedures carry inherent risks that cannot be eliminated, including but not limited to:

a) Physical Risks: Pain, discomfort, infection, scarring, nerve damage, organ damage, loss of bodily function, chronic medical conditions, and death.

b) Psychological Risks: Personality changes, identity disruption, emotional dysregulation, relationship deterioration, cognitive alterations, and development of enhancement-related psychological conditions.

c) Social Risks: Alienation from unenhanced individuals, discrimination, relationship termination, employment complications, and social isolation.

d) Economic Risks: Inability to work, loss of income, medical expenses not covered by warranty, and dependency on maintenance services.

e) Unknown Risks: Risks not currently known or characterized due to the novel nature of enhancement technology.

Section 1.3: Acceptance of All Risks

Recipient accepts ALL risks associated with enhancement, including risks known, unknown, foreseeable, and unforeseeable, ordinary and extraordinary.

---

ARTICLE II: RELEASE OF LIABILITY

Section 2.1: General Release

Recipient hereby RELEASES, WAIVES, DISCHARGES, AND COVENANTS NOT TO SUE Unzyme Laboratories Corporation, its parent companies, subsidiaries, affiliates, officers, directors, employees, agents, contractors, successors, and assigns (collectively “Released Parties”) from any and all liability, claims, demands, actions, or causes of action arising out of or related to enhancement procedures, products, or services.

Section 2.2: Scope of Release

This release applies to claims arising from:

a) Negligence (ordinary or gross) by Released Parties b) Defects in enhancement products or services c) Failure of enhancement systems to perform as expected d) Complications arising from enhancement procedures e) Psychological or personality changes resulting from enhancement f) Physical injury, disability, or death g) Economic loss or damage h) Any other harm arising from or related to enhancement

Section 2.3: Exclusions

This release does not apply to claims arising from:

a) Intentional misconduct by Released Parties b) Fraud in the inducement of this agreement c) Claims that cannot be waived under applicable law

Section 2.4: Future Claims

This release applies to claims arising now and in the future, including claims that Recipient does not currently know exist or anticipate.

---

ARTICLE III: INDEMNIFICATION

Section 3.1: Indemnity Obligation

Recipient agrees to INDEMNIFY, DEFEND, AND HOLD HARMLESS the Released Parties from any claims, damages, losses, expenses (including attorney fees), or liabilities arising from:

a) Recipient’s enhancement or use of enhanced capabilities b) Claims by third parties arising from Recipient’s enhancement c) Recipient’s breach of this agreement or the Enhancement Agreement d) Recipient’s violation of law using enhanced capabilities

Section 3.2: Third Party Claims

If Recipient injures another person using enhanced capabilities, whether intentionally or accidentally, Recipient accepts full responsibility for such injury and will defend and hold harmless Released Parties from any resulting claims.

---

ARTICLE IV: LIMITATION OF DAMAGES

Section 4.1: Cap on Damages

IN NO EVENT SHALL RELEASED PARTIES’ TOTAL LIABILITY EXCEED THE AMOUNT PAID BY RECIPIENT FOR ENHANCEMENT SERVICES, REGARDLESS OF THE NATURE OF THE CLAIM.

Section 4.2: Exclusion of Consequential Damages

IN NO EVENT SHALL RELEASED PARTIES BE LIABLE FOR INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO:

• Lost income or earning capacity
• Loss of enjoyment of life
• Pain and suffering
• Emotional distress
• Loss of consortium or relationship damage
• Diminished quality of life

Section 4.3: Warranty Limitations

All enhancement products and services are provided “AS IS” following the warranty period. No implied warranties of merchantability or fitness for particular purpose apply beyond the express warranty period.

---

ARTICLE V: DISPUTE RESOLUTION

Section 5.1: Mandatory Arbitration

Any dispute arising from or relating to enhancement products, services, or this agreement shall be resolved exclusively through binding arbitration administered by the American Arbitration Association under its Commercial Arbitration Rules.

Section 5.2: Waiver of Jury Trial

RECIPIENT WAIVES ANY RIGHT TO A JURY TRIAL for any dispute covered by this agreement.

Section 5.3: Class Action Waiver

RECIPIENT WAIVES ANY RIGHT TO PARTICIPATE IN CLASS ACTIONS. All disputes must be brought in Recipient’s individual capacity.

Section 5.4: Location

Arbitration shall take place in Wilmington, Delaware, unless parties agree otherwise in writing.

---

ARTICLE VI: GENERAL PROVISIONS

Section 6.1: Governing Law

This agreement is governed by the laws of the State of Delaware, without regard to conflict of laws principles.

Section 6.2: Severability

If any provision is found unenforceable, remaining provisions continue in full effect. Unenforceable provisions will be modified to minimum extent necessary for enforceability.

Section 6.3: Entire Agreement

This agreement, together with the Informed Consent, Enhancement Agreement, and other documents referenced herein, constitutes the entire agreement between parties regarding liability limitations.

Section 6.4: No Oral Modification

This agreement may not be modified except in writing signed by both parties.

Section 6.5: Binding Effect

This agreement binds Recipient and Recipient’s heirs, executors, administrators, and assigns.

---

ACKNOWLEDGMENT

I HAVE CAREFULLY READ THIS AGREEMENT. I UNDERSTAND THAT BY SIGNING, I AM GIVING UP SUBSTANTIAL LEGAL RIGHTS. I SIGN THIS AGREEMENT VOLUNTARILY AND OF MY OWN FREE WILL.

I UNDERSTAND THAT THIS IS A LEGALLY BINDING AGREEMENT AND THAT I MAY CONSULT AN ATTORNEY BEFORE SIGNING.

---

Recipient Signature: _________________________________

Printed Name: _________________________________

Date: _________________________________

Witness Signature: _________________________________

Witness Printed Name: _________________________________

---

Document must be signed prior to any enhancement procedure. Retain copy for your records.